Etirinotecan Pegol (NKTR-102) in Third-line Treatment of...

  • Main
  • 2017 / 10
  • Etirinotecan Pegol (NKTR-102) in Third-line Treatment of...
Clinical Lung Cancer 2017 / 10

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

Aggarwal, Charu, Cohen, Roger B., Yu, Eddy, Hwang, Wei-Ting, Bauml, Joshua M., Alley, Evan, Evans, Tracey L., Langer, Corey J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2017.10.007
Date:
October, 2017
File:
PDF, 354 KB
english, 2017
Conversion to is in progress
Conversion to is failed